Todd A. Fehniger

Todd A. Fehniger, MD, PhD

  • Bone Marrow Transplant
  • Cancer (Oncology)

Sees Patients For

Lymphoma, cellular therapy and bone marrow transplantation

Patients Seen At

Hospital Affiliations

  • Barnes-Jewish Hospital

Board Certifications

  • Internal Medicine

Academic Title(s)

Professor, Medicine
Division of Oncology
Section, Bone Marrow Transplant

Languages

  • English

Education

PhD

2000 Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, College of Medicine and Public Health Columbus, Ohio

BS

1994 Biological Sciences, SUNY, Buffalo, New York

Fellowship

2008 Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri

Residency

2004 Internal Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, Missouri

Medical Degree

2002 The Ohio State University, College of Medicine and Public Health, Columbus, Ohio

Publications & Research

Search PubMed for publications »

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Company Name: Cyto-Sen TherapeuticsRoyalties: $1 - $9,999Equity: YesConsulting/Advisory Board: $1 - $9,999Speaker Fees: $1 - $9,999Reporting Date: 05/01/2020
Company Name: Orca TherapeuticsRoyalties: $1 - $9,999Equity: YesConsulting/Advisory Board: $1 - $9,999Speaker Fees: $1 - $9,999Reporting Date: 05/01/2020